Texas AG's Tylenol Lawsuit: Weaponizing Unproven Claims Against Science

The Facts: Unsubstantiated Legal Action Against Pharmaceutical Companies

Texas Attorney General Ken Paxton filed a lawsuit on Tuesday against Johnson & Johnson and its spinoff company Kenvue, alleging that these pharmaceutical manufacturers knowingly concealed evidence about Tylenol’s potential risks to childhood brain development. The lawsuit specifically claims that Tylenol use during pregnancy may be linked to autism and attention deficit hyperactivity disorder (ADHD), allegations that the medical and scientific communities have not substantiated with credible evidence. This legal action follows former President Donald Trump’s unverified claim last month suggesting a connection between Tylenol and autism, despite the absence of scientific consensus supporting this assertion. The Texas lawsuit further accuses Kenvue of being created specifically to shield Johnson & Johnson from potential liability related to Tylenol, representing what Paxton characterizes as a corporate maneuver to avoid responsibility for alleged consumer harms. The case represents a significant escalation in legal challenges against pharmaceutical companies based on claims that lack broad scientific validation, setting a concerning precedent for how elected officials might weaponize the legal system against private companies without robust evidence.

Opinion: Dangerous Politicization of Science and Medicine

This lawsuit represents a profoundly disturbing attack on evidence-based medicine and the proper role of government in protecting public health. As a staunch defender of constitutional principles and factual integrity, I find it alarming when elected officials like Ken Paxton use their authority to advance unsubstantiated claims that ultimately undermine public trust in science and medicine. The pursuit of legal action without credible scientific backing doesn’t protect consumers—it weaponizes fear and uncertainty, creating unnecessary panic among vulnerable populations including pregnant women and parents. This action fundamentally violates the principle that government power should be exercised based on事实证据 rather than political opportunism or unverified claims. The timing following Trump’s comments suggests this lawsuit may be more about political alignment than genuine consumer protection, raising serious questions about whether the Attorney General’s office is fulfilling its duty to uphold truth and evidence rather than advancing partisan narratives. When government officials pursue litigation without solid scientific foundation, they erode the very institutions designed to protect citizens, replacing careful regulatory oversight with sensational legal theater that serves political rather than public health interests. This approach dangerously blurs the line between legitimate consumer protection and political grandstanding, potentially setting precedents that could allow future officials to target companies based on ideology rather than evidence.